Expert Information For Journalists

Connecting reporters to sources and resources

HOME  Public Relations  Pharmacy Safety  Acupuncture  Home Building  Yellow Perch 
Nav Links

Dennis Tribble, PharmD
 
Chief Pharmacy Officer and Chief Technology Officer for FHT, Inc., a wholly owned subsidiary of Baxa Corporation
 
Dennis Tribble is an expert on hospital pharmacy safety and related medication safety issues.  He is most passionate about the need for a complete restructuring of the pharmacy practice paradigm and the role technology will play in bringing about that vision.
Tribble, a pharmacist and software engineer, serves as the Chairman of the American Society of Health-System Pharmacists (ASHP) Section on Pharmacy Informatics and Technology (SOPIT). In addition he is a Past President of the Illinois Council of Health-System Pharmacists and charter member of the Pharmacy Informatics Task Force for the Healthcare Information and Management Systems Society (HIMSS). Extensively published on hospital pharmacy operations and pharmacy informatics, he serves as a reviewer on automation for the American Journal of Health-System Pharmacy and is listed as an inventor on nine patents related to automation of IV admixtures.
 
Prior to joining FHT, Inc., Tribble was the Chief Medical Officer at Baxa Corporation where he led the development of internal and external products. He received his undergraduate degree from Muhlenberg College, Allentown, Penn., and his Doctor of Pharmacy degree from the University of the Pacific School of Pharmacy in Stockton, Calif.  He also completed a residency in Hospital Pharmacy at The Moses H. Cone Memorial Hospital in Greensboro, N.C.
 
 
 
If you would like to submit a question by e-mail, click here. 

 
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock®  Set Saver, Rapid-Fill™ Automated Syringe Fillers, ExactaMedOral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and ExactaMix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities.  Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.
 
About FHT, Inc.
Founded in 1998, FHT, Inc. is now a wholly-owned subsidiary of Baxa Corporation. FHT Inc.’s solutions deliver quantum-leap improvements in key IV room performance metrics: accuracy, patient safety, clinician safety, speed, cost reduction, and regulatory compliance.  More information is available at www.fhtinc.com
 
If you would like to submit a question by e-mail, click here
Baxa Corporation technical papers of related interest:
Overview of USP 797: Pharmaceutical Compounding – Sterile Preparations
Oral Medication Dispensers in Clinical Research
Enteral Feeding Misconnections
Environmental Controls for Sterile Compounding
The Limitations of Isolators
Pharmacy Considerations for Syringe Batch Processing
Safe Handling of Hazardous Drugs
USP 797 Requirements for Automated Compounders
Technical Bulletin for Risk Level Assessment
Outsourcing for USP 797